Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases.
Journal
NPJ genomic medicine
ISSN: 2056-7944
Titre abrégé: NPJ Genom Med
Pays: England
ID NLM: 101685193
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
received:
13
03
2023
accepted:
29
09
2023
medline:
17
10
2023
pubmed:
17
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
Von Willebrand disease (VWD) is a common bleeding disorder caused by mutations in the von Willebrand factor gene (VWF). The true global prevalence of VWD has not been accurately established. We estimated the worldwide and within-population prevalence of inherited VWD by analyzing exome and genome data of 141,456 individuals gathered by the genome Aggregation Database (gnomAD). We also extended our data deepening by mining the main databases containing VWF variants i.e., the Leiden Open Variation Database (LOVD) and the Human Gene Mutation Database (HGMD) with the goal to explore the global mutational spectrum of VWD. A total of 4,313 VWF variants were identified in the gnomAD population, of which 505 were predicted to be pathogenic or already reported to be associated with VWD. Among the 282,912 alleles analyzed, 31,785 were affected by the aforementioned variants. The global prevalence of dominant VWD in 1000 individuals was established to be 74 for type 1, 3 for 2A, 3 for 2B and 6 for 2M. The global prevalences for recessive VWD forms (type 2N and type 3) were 0.31 and 0.7 in 1000 individuals, respectively. This comprehensive analysis provided a global mutational landscape of VWF by means of 927 already reported variants in the HGMD and LOVD datasets and 287 novel pathogenic variants identified in the gnomAD. Our results reveal that there is a considerably higher than expected prevalence of putative disease alleles and variants associated with VWD and suggest that a large number of VWD patients are undiagnosed.
Identifiants
pubmed: 37845247
doi: 10.1038/s41525-023-00375-8
pii: 10.1038/s41525-023-00375-8
pmc: PMC10579253
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31Informations de copyright
© 2023. Springer Nature Limited and Centre of Excellence in Genomic Medicine Research, King Abdulaziz University.
Références
Ruggeri, Z. M. von Willebrand factor. J. Clin. Investig. 99, 559–564 (1997).
doi: 10.1172/JCI119195
pubmed: 9045854
pmcid: 507834
Mojzisch, A. & Brehm, M. A. The manifold cellular functions of von willebrand factor. Cells 10, 2351 (2021).
doi: 10.3390/cells10092351
pubmed: 34572000
pmcid: 8466076
Zhou, Y. F. et al. Sequence and structure relationships within von Willebrand factor. Blood 120, 449–458 (2012).
doi: 10.1182/blood-2012-01-405134
pubmed: 22490677
pmcid: 3398765
Peyvandi, F., Garagiola, I. & Baronciani, L. Role of von Willebrand factor in the haemostasis. Blood Transfus. 9, s3_s8. (2011).
pmcid: 3159913
Lenting, P. J., Casari, C., Christophe, O. D. & Denis, C. V. von Willebrand factor: the old, the new and the unknown. J. Thrombosis Haemost. 10, 2428–2437 (2012).
doi: 10.1111/jth.12008
Ginsburg, D. et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 228, 1401–1406 (1985).
doi: 10.1126/science.3874428
pubmed: 3874428
Lynch, D. C. et al. Livingston, Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell 41, 49–56 (1985).
doi: 10.1016/0092-8674(85)90060-1
pubmed: 3873280
Sadler, J. E. et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc. Natl. Acad. Sci. USA 82, 6394–6398 (1985).
doi: 10.1073/pnas.82.19.6394
pubmed: 2864688
pmcid: 390722
Verweij, C. L. et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony screening and mapping of the chromosomal gene. Nucleic Acids Res. 13, 4699–4717 (1985).
doi: 10.1093/nar/13.13.4699
pubmed: 3875078
pmcid: 321821
Mancuso, D. J. et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 30, 253–269 (1991).
doi: 10.1021/bi00215a036
pubmed: 1988024
Sadler, J. E. et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. JTH 4, 2103–2114 (2006).
pubmed: 16889557
de Jong, A. & Eikenboom, J. Von Willebrand disease mutation spectrum and associated mutation mechanisms. Thrombosis Res. 159, 65–75 (2017).
doi: 10.1016/j.thromres.2017.09.025
Baronciani, L. et al. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Adv. 5, 2987–3001 (2021).
doi: 10.1182/bloodadvances.2020003397
pubmed: 34351388
pmcid: 8361454
Christopherson, P. A. et al. Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program. J. Thromb. Haemost. 20, 1576–1588 (2022).
doi: 10.1111/jth.15713
pubmed: 35343054
Seidizadeh, O. et al. Phenotypic and genetic characterization of the Milan cohort of von Willebrand disease type 2. Blood Adv. 6, 4031–4040 (2022).
doi: 10.1182/bloodadvances.2022007216
pubmed: 35452508
pmcid: 9278302
Rodeghiero, F., Castaman, G. & Dini, E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 69, 454–459 (1987).
doi: 10.1182/blood.V69.2.454.454
pubmed: 3492222
Werner, E. J. et al. Prevalence of von Willebrand disease in children: a multiethnic study. J. Pediatr. 123, 893–898 (1993).
doi: 10.1016/S0022-3476(05)80384-1
pubmed: 8229521
Bowman, M., Hopman, W. M., Rapson, D., Lillicrap, D. & James, P. The prevalence of symptomatic von Willebrand disease in primary care practice. J. Thrombosis Haemost. 8, 213–216 (2010).
doi: 10.1111/j.1538-7836.2009.03661.x
Bloom, Al. von Willebrand factor: clinical features of inherited and acquired disorders. In Mayo Clinic Proceedings 1991 Jul 1 (Vol. 66, pp. 743–751).
Pugh, J. et al. Use of big data to estimate prevalence of defective DNA repair variants in the US Population. JAMA Dermatol. 155, 72–78 (2019).
doi: 10.1001/jamadermatol.2018.4473
pubmed: 30516811
Hughes, B. G., Harrison, P. M. & Hekimi, S. Estimating the occurrence of primary ubiquinone deficiency by analysis of large-scale sequencing data. Sci. Rep. 7, 17744 (2017).
doi: 10.1038/s41598-017-17564-y
pubmed: 29255295
pmcid: 5735152
Asselta, R. et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood 130, e1–e6 (2017).
doi: 10.1182/blood-2017-04-780148
pubmed: 28615222
Sidonio, R. F., Haley, K. M. & Fallaize, D. Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data. Haemophilia 23, 743–749 (2017).
doi: 10.1111/hae.13292
pubmed: 28636092
Corrales-Medina, F. F. et al. A need to increase von Willebrand disease awareness: vwdtest.com - A global initiative to help address this gap. Blood Rev. 58, 101018 (2023).
doi: 10.1016/j.blre.2022.101018
pubmed: 36210240
Johnsen, J. M. et al. NHLBI Exome Sequencing Project. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood 122, 590–597 (2013).
doi: 10.1182/blood-2013-02-485094
pubmed: 23690449
pmcid: 3724194
Wang, Q. Y. et al. Characterizing polymorphisms and allelic diversity of von W illebrand factor gene in the 1000 Genomes. J. Thrombosis Haemost. 11, 261–269 (2013).
doi: 10.1111/jth.12093
Bellissimo, D. B. et al. VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood 119, 2135–2140 (2012).
doi: 10.1182/blood-2011-10-384610
pubmed: 22197721
pmcid: 3311248
Hampshire, D. J. Goodeve AC. p.P2063S: a neutral VWF variant masquerading as a mutation. Ann. Hematol. 93, 505–506 (2014).
doi: 10.1007/s00277-013-1817-y
pubmed: 23775583
Jian, X., Boerwinkle, E. & Liu, X. In silico tools for splicing defect prediction: a survey from the viewpoint of end users. Genet. Med. 16, 497–503 (2014).
doi: 10.1038/gim.2013.176
pubmed: 24263461
Kaler, S. G., Ferreira, C. R. & Yam, L. S. Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD). Mol. Genet. Metab. Rep. 24, 100602 (2020).
pubmed: 32528851
pmcid: 7283148
Soussi, T., Leroy, B., Devir, M. & Rosenberg, S. High prevalence of cancer‐associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering. Hum. Mutat. 40, 516–524. (2019).
pubmed: 30720243
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
doi: 10.1038/s41586-020-2308-7
pubmed: 32461654
pmcid: 7334197
Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acid Res. 31, 3568–3571. (2003).
doi: 10.1093/nar/gkg616
pubmed: 12824367
pmcid: 169022
Reese, M. G., Eeckman, F. H., Kulp, D. & Haussler, D. Improved splice site detection in genie. J. Comp. Biol. 4, 311–323 (1997).
doi: 10.1089/cmb.1997.4.311
Rentzsch, P., Schubach, M., Shendure, J. & Kircher, M. CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 13, 31 (2021).
doi: 10.1186/s13073-021-00835-9
pubmed: 33618777
pmcid: 7901104
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
doi: 10.1038/nprot.2009.86
pubmed: 19561590
Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
doi: 10.1038/nmeth0410-248
pubmed: 20354512
pmcid: 2855889
Felsenstein, J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17, 368–376 (1981).
doi: 10.1007/BF01734359
pubmed: 7288891
Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
doi: 10.1038/nmeth0810-575
pubmed: 20676075
Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
doi: 10.1093/nar/gkr407
pubmed: 21727090
pmcid: 3177186
Shihab, H. A. et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum. Mutat. 34, 57–65 (2013).
doi: 10.1002/humu.22225
pubmed: 23033316